DaVita stock trades steady as chronic kidney care demand supports earnings trajectory
DaVita Inc. stock is trading steadily, reflecting stable expectations driven by consistent demand for chronic kidney care services. The company, a leading provider of dialysis and kidney care, balances reimbursement pressures with patient volume growth and capital allocation strategies. Its earnings trajectory remains a …